Global Alpha L-Iduronidase Market Growth 2024-2030

Report ID: 2897072 | Published Date: Dec 2025 | No. of Page: 112 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story

Impact of U.S Tarrifs Analyzed 2025

1 Scope of the Report

    1.1 Market Introduction

    1.2 Years Considered

    1.3 Research Objectives

    1.4 Market Research Methodology

    1.5 Research Process and Data Source

    1.6 Economic Indicators

    1.7 Currency Considered

    1.8 Market Estimation Caveats

2 Executive Summary

    2.1 World Market Overview

        2.1.1 Global Alpha L-Iduronidase Annual Sales 2019-2030

        2.1.2 World Current & Future Analysis for Alpha L-Iduronidase by Geographic Region, 2019, 2023 & 2030

        2.1.3 World Current & Future Analysis for Alpha L-Iduronidase by Country/Region, 2019, 2023 & 2030

    2.2 Alpha L-Iduronidase Segment by Type

        2.2.1 IDUA

        2.2.2 EC 3.2.1.76

    2.3 Alpha L-Iduronidase Sales by Type

        2.3.1 Global Alpha L-Iduronidase Sales Market Share by Type (2019-2024)

        2.3.2 Global Alpha L-Iduronidase Revenue and Market Share by Type (2019-2024)

        2.3.3 Global Alpha L-Iduronidase Sale Price by Type (2019-2024)

    2.4 Alpha L-Iduronidase Segment by Application

        2.4.1 Oncology

        2.4.2 Dermatology

        2.4.3 Immunology

        2.4.4 Musculoskeletal Disorders

    2.5 Alpha L-Iduronidase Sales by Application

        2.5.1 Global Alpha L-Iduronidase Sale Market Share by Application (2019-2024)

        2.5.2 Global Alpha L-Iduronidase Revenue and Market Share by Application (2019-2024)

        2.5.3 Global Alpha L-Iduronidase Sale Price by Application (2019-2024)

3 Global Alpha L-Iduronidase by Company

    3.1 Global Alpha L-Iduronidase Breakdown Data by Company

        3.1.1 Global Alpha L-Iduronidase Annual Sales by Company (2019-2024)

        3.1.2 Global Alpha L-Iduronidase Sales Market Share by Company (2019-2024)

    3.2 Global Alpha L-Iduronidase Annual Revenue by Company (2019-2024)

        3.2.1 Global Alpha L-Iduronidase Revenue by Company (2019-2024)

        3.2.2 Global Alpha L-Iduronidase Revenue Market Share by Company (2019-2024)

    3.3 Global Alpha L-Iduronidase Sale Price by Company

    3.4 Key Manufacturers Alpha L-Iduronidase Producing Area Distribution, Sales Area, Product Type

        3.4.1 Key Manufacturers Alpha L-Iduronidase Product Location Distribution

        3.4.2 Players Alpha L-Iduronidase Products Offered

    3.5 Market Concentration Rate Analysis

        3.5.1 Competition Landscape Analysis

        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)

    3.6 New Products and Potential Entrants

    3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Alpha L-Iduronidase by Geographic Region

    4.1 World Historic Alpha L-Iduronidase Market Size by Geographic Region (2019-2024)

        4.1.1 Global Alpha L-Iduronidase Annual Sales by Geographic Region (2019-2024)

        4.1.2 Global Alpha L-Iduronidase Annual Revenue by Geographic Region (2019-2024)

    4.2 World Historic Alpha L-Iduronidase Market Size by Country/Region (2019-2024)

        4.2.1 Global Alpha L-Iduronidase Annual Sales by Country/Region (2019-2024)

        4.2.2 Global Alpha L-Iduronidase Annual Revenue by Country/Region (2019-2024)

    4.3 Americas Alpha L-Iduronidase Sales Growth

    4.4 APAC Alpha L-Iduronidase Sales Growth

    4.5 Europe Alpha L-Iduronidase Sales Growth

    4.6 Middle East & Africa Alpha L-Iduronidase Sales Growth

5 Americas

    5.1 Americas Alpha L-Iduronidase Sales by Country

        5.1.1 Americas Alpha L-Iduronidase Sales by Country (2019-2024)

        5.1.2 Americas Alpha L-Iduronidase Revenue by Country (2019-2024)

    5.2 Americas Alpha L-Iduronidase Sales by Type

    5.3 Americas Alpha L-Iduronidase Sales by Application

    5.4 United States

    5.5 Canada

    5.6 Mexico

    5.7 Brazil

6 APAC

    6.1 APAC Alpha L-Iduronidase Sales by Region

        6.1.1 APAC Alpha L-Iduronidase Sales by Region (2019-2024)

        6.1.2 APAC Alpha L-Iduronidase Revenue by Region (2019-2024)

    6.2 APAC Alpha L-Iduronidase Sales by Type

    6.3 APAC Alpha L-Iduronidase Sales by Application

    6.4 China

    6.5 Japan

    6.6 South Korea

    6.7 Southeast Asia

    6.8 India

    6.9 Australia

    6.10 China Taiwan

7 Europe

    7.1 Europe Alpha L-Iduronidase by Country

        7.1.1 Europe Alpha L-Iduronidase Sales by Country (2019-2024)

        7.1.2 Europe Alpha L-Iduronidase Revenue by Country (2019-2024)

    7.2 Europe Alpha L-Iduronidase Sales by Type

    7.3 Europe Alpha L-Iduronidase Sales by Application

    7.4 Germany

    7.5 France

    7.6 UK

    7.7 Italy

    7.8 Russia

8 Middle East & Africa

    8.1 Middle East & Africa Alpha L-Iduronidase by Country

        8.1.1 Middle East & Africa Alpha L-Iduronidase Sales by Country (2019-2024)

        8.1.2 Middle East & Africa Alpha L-Iduronidase Revenue by Country (2019-2024)

    8.2 Middle East & Africa Alpha L-Iduronidase Sales by Type

    8.3 Middle East & Africa Alpha L-Iduronidase Sales by Application

    8.4 Egypt

    8.5 South Africa

    8.6 Israel

    8.7 Turkey

    8.8 GCC Countries

9 Market Drivers, Challenges and Trends

    9.1 Market Drivers & Growth Opportunities

    9.2 Market Challenges & Risks

    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

    10.1 Raw Material and Suppliers

    10.2 Manufacturing Cost Structure Analysis of Alpha L-Iduronidase

    10.3 Manufacturing Process Analysis of Alpha L-Iduronidase

    10.4 Industry Chain Structure of Alpha L-Iduronidase

11 Marketing, Distributors and Customer

    11.1 Sales Channel

        11.1.1 Direct Channels

        11.1.2 Indirect Channels

    11.2 Alpha L-Iduronidase Distributors

    11.3 Alpha L-Iduronidase Customer

12 World Forecast Review for Alpha L-Iduronidase by Geographic Region

    12.1 Global Alpha L-Iduronidase Market Size Forecast by Region

        12.1.1 Global Alpha L-Iduronidase Forecast by Region (2025-2030)

        12.1.2 Global Alpha L-Iduronidase Annual Revenue Forecast by Region (2025-2030)

    12.2 Americas Forecast by Country

    12.3 APAC Forecast by Region

    12.4 Europe Forecast by Country

    12.5 Middle East & Africa Forecast by Country

    12.6 Global Alpha L-Iduronidase Forecast by Type

    12.7 Global Alpha L-Iduronidase Forecast by Application

13 Key Players Analysis

    13.1 ArmaGen Inc

        13.1.1 ArmaGen Inc Company Information

        13.1.2 ArmaGen Inc Alpha L-Iduronidase Product Portfolios and Specifications

        13.1.3 ArmaGen Inc Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2024)

        13.1.4 ArmaGen Inc Main Business Overview

        13.1.5 ArmaGen Inc Latest Developments

    13.2 BioStrategies LC

        13.2.1 BioStrategies LC Company Information

        13.2.2 BioStrategies LC Alpha L-Iduronidase Product Portfolios and Specifications

        13.2.3 BioStrategies LC Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2024)

        13.2.4 BioStrategies LC Main Business Overview

        13.2.5 BioStrategies LC Latest Developments

    13.3 Denali Therapeutics Inc

        13.3.1 Denali Therapeutics Inc Company Information

        13.3.2 Denali Therapeutics Inc Alpha L-Iduronidase Product Portfolios and Specifications

        13.3.3 Denali Therapeutics Inc Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2024)

        13.3.4 Denali Therapeutics Inc Main Business Overview

        13.3.5 Denali Therapeutics Inc Latest Developments

    13.4 EdiGene Inc

        13.4.1 EdiGene Inc Company Information

        13.4.2 EdiGene Inc Alpha L-Iduronidase Product Portfolios and Specifications

        13.4.3 EdiGene Inc Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2024)

        13.4.4 EdiGene Inc Main Business Overview

        13.4.5 EdiGene Inc Latest Developments

    13.5 Gain Therapeutics Inc

        13.5.1 Gain Therapeutics Inc Company Information

        13.5.2 Gain Therapeutics Inc Alpha L-Iduronidase Product Portfolios and Specifications

        13.5.3 Gain Therapeutics Inc Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2024)

        13.5.4 Gain Therapeutics Inc Main Business Overview

        13.5.5 Gain Therapeutics Inc Latest Developments

    13.6 Immusoft Corp

        13.6.1 Immusoft Corp Company Information

        13.6.2 Immusoft Corp Alpha L-Iduronidase Product Portfolios and Specifications

        13.6.3 Immusoft Corp Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2024)

        13.6.4 Immusoft Corp Main Business Overview

        13.6.5 Immusoft Corp Latest Developments

    13.7 JCR Pharmaceuticals Co Ltd

        13.7.1 JCR Pharmaceuticals Co Ltd Company Information

        13.7.2 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product Portfolios and Specifications

        13.7.3 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2024)

        13.7.4 JCR Pharmaceuticals Co Ltd Main Business Overview

        13.7.5 JCR Pharmaceuticals Co Ltd Latest Developments

    13.8 Orchard Therapeutics Plc

        13.8.1 Orchard Therapeutics Plc Company Information

        13.8.2 Orchard Therapeutics Plc Alpha L-Iduronidase Product Portfolios and Specifications

        13.8.3 Orchard Therapeutics Plc Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2024)

        13.8.4 Orchard Therapeutics Plc Main Business Overview

        13.8.5 Orchard Therapeutics Plc Latest Developments

    13.9 Ossianix Inc

        13.9.1 Ossianix Inc Company Information

        13.9.2 Ossianix Inc Alpha L-Iduronidase Product Portfolios and Specifications

        13.9.3 Ossianix Inc Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2024)

        13.9.4 Ossianix Inc Main Business Overview

        13.9.5 Ossianix Inc Latest Developments

    13.10 Rain Bio Inc

        13.10.1 Rain Bio Inc Company Information

        13.10.2 Rain Bio Inc Alpha L-Iduronidase Product Portfolios and Specifications

        13.10.3 Rain Bio Inc Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2024)

        13.10.4 Rain Bio Inc Main Business Overview

        13.10.5 Rain Bio Inc Latest Developments

    13.11 RegenxBio Inc

        13.11.1 RegenxBio Inc Company Information

        13.11.2 RegenxBio Inc Alpha L-Iduronidase Product Portfolios and Specifications

        13.11.3 RegenxBio Inc Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2024)

        13.11.4 RegenxBio Inc Main Business Overview

        13.11.5 RegenxBio Inc Latest Developments

    13.12 Tega Therapeutics Inc

        13.12.1 Tega Therapeutics Inc Company Information

        13.12.2 Tega Therapeutics Inc Alpha L-Iduronidase Product Portfolios and Specifications

        13.12.3 Tega Therapeutics Inc Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2024)

        13.12.4 Tega Therapeutics Inc Main Business Overview

        13.12.5 Tega Therapeutics Inc Latest Developments

14 Research Findings and Conclusion

List of Tables

    Table 1. Alpha L-Iduronidase Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)

    Table 2. Alpha L-Iduronidase Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)

    Table 3. Major Players of IDUA

    Table 4. Major Players of EC 3.2.1.76

    Table 5. Global Alpha L-Iduronidase Sales by Type (2019-2024) & (K Units)

    Table 6. Global Alpha L-Iduronidase Sales Market Share by Type (2019-2024)

    Table 7. Global Alpha L-Iduronidase Revenue by Type (2019-2024) & ($ million)

    Table 8. Global Alpha L-Iduronidase Revenue Market Share by Type (2019-2024)

    Table 9. Global Alpha L-Iduronidase Sale Price by Type (2019-2024) & (US$/Unit)

    Table 10. Global Alpha L-Iduronidase Sales by Application (2019-2024) & (K Units)

    Table 11. Global Alpha L-Iduronidase Sales Market Share by Application (2019-2024)

    Table 12. Global Alpha L-Iduronidase Revenue by Application (2019-2024)

    Table 13. Global Alpha L-Iduronidase Revenue Market Share by Application (2019-2024)

    Table 14. Global Alpha L-Iduronidase Sale Price by Application (2019-2024) & (US$/Unit)

    Table 15. Global Alpha L-Iduronidase Sales by Company (2019-2024) & (K Units)

    Table 16. Global Alpha L-Iduronidase Sales Market Share by Company (2019-2024)

    Table 17. Global Alpha L-Iduronidase Revenue by Company (2019-2024) ($ Millions)

    Table 18. Global Alpha L-Iduronidase Revenue Market Share by Company (2019-2024)

    Table 19. Global Alpha L-Iduronidase Sale Price by Company (2019-2024) & (US$/Unit)

    Table 20. Key Manufacturers Alpha L-Iduronidase Producing Area Distribution and Sales Area

    Table 21. Players Alpha L-Iduronidase Products Offered

    Table 22. Alpha L-Iduronidase Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)

    Table 23. New Products and Potential Entrants

    Table 24. Mergers & Acquisitions, Expansion

    Table 25. Global Alpha L-Iduronidase Sales by Geographic Region (2019-2024) & (K Units)

    Table 26. Global Alpha L-Iduronidase Sales Market Share Geographic Region (2019-2024)

    Table 27. Global Alpha L-Iduronidase Revenue by Geographic Region (2019-2024) & ($ millions)

    Table 28. Global Alpha L-Iduronidase Revenue Market Share by Geographic Region (2019-2024)

    Table 29. Global Alpha L-Iduronidase Sales by Country/Region (2019-2024) & (K Units)

    Table 30. Global Alpha L-Iduronidase Sales Market Share by Country/Region (2019-2024)

    Table 31. Global Alpha L-Iduronidase Revenue by Country/Region (2019-2024) & ($ millions)

    Table 32. Global Alpha L-Iduronidase Revenue Market Share by Country/Region (2019-2024)

    Table 33. Americas Alpha L-Iduronidase Sales by Country (2019-2024) & (K Units)

    Table 34. Americas Alpha L-Iduronidase Sales Market Share by Country (2019-2024)

    Table 35. Americas Alpha L-Iduronidase Revenue by Country (2019-2024) & ($ Millions)

    Table 36. Americas Alpha L-Iduronidase Revenue Market Share by Country (2019-2024)

    Table 37. Americas Alpha L-Iduronidase Sales by Type (2019-2024) & (K Units)

    Table 38. Americas Alpha L-Iduronidase Sales by Application (2019-2024) & (K Units)

    Table 39. APAC Alpha L-Iduronidase Sales by Region (2019-2024) & (K Units)

    Table 40. APAC Alpha L-Iduronidase Sales Market Share by Region (2019-2024)

    Table 41. APAC Alpha L-Iduronidase Revenue by Region (2019-2024) & ($ Millions)

    Table 42. APAC Alpha L-Iduronidase Revenue Market Share by Region (2019-2024)

    Table 43. APAC Alpha L-Iduronidase Sales by Type (2019-2024) & (K Units)

    Table 44. APAC Alpha L-Iduronidase Sales by Application (2019-2024) & (K Units)

    Table 45. Europe Alpha L-Iduronidase Sales by Country (2019-2024) & (K Units)

    Table 46. Europe Alpha L-Iduronidase Sales Market Share by Country (2019-2024)

    Table 47. Europe Alpha L-Iduronidase Revenue by Country (2019-2024) & ($ Millions)

    Table 48. Europe Alpha L-Iduronidase Revenue Market Share by Country (2019-2024)

    Table 49. Europe Alpha L-Iduronidase Sales by Type (2019-2024) & (K Units)

    Table 50. Europe Alpha L-Iduronidase Sales by Application (2019-2024) & (K Units)

    Table 51. Middle East & Africa Alpha L-Iduronidase Sales by Country (2019-2024) & (K Units)

    Table 52. Middle East & Africa Alpha L-Iduronidase Sales Market Share by Country (2019-2024)

    Table 53. Middle East & Africa Alpha L-Iduronidase Revenue by Country (2019-2024) & ($ Millions)

    Table 54. Middle East & Africa Alpha L-Iduronidase Revenue Market Share by Country (2019-2024)

    Table 55. Middle East & Africa Alpha L-Iduronidase Sales by Type (2019-2024) & (K Units)

    Table 56. Middle East & Africa Alpha L-Iduronidase Sales by Application (2019-2024) & (K Units)

    Table 57. Key Market Drivers & Growth Opportunities of Alpha L-Iduronidase

    Table 58. Key Market Challenges & Risks of Alpha L-Iduronidase

    Table 59. Key Industry Trends of Alpha L-Iduronidase

    Table 60. Alpha L-Iduronidase Raw Material

    Table 61. Key Suppliers of Raw Materials

    Table 62. Alpha L-Iduronidase Distributors List

    Table 63. Alpha L-Iduronidase Customer List

    Table 64. Global Alpha L-Iduronidase Sales Forecast by Region (2025-2030) & (K Units)

    Table 65. Global Alpha L-Iduronidase Revenue Forecast by Region (2025-2030) & ($ millions)

    Table 66. Americas Alpha L-Iduronidase Sales Forecast by Country (2025-2030) & (K Units)

    Table 67. Americas Alpha L-Iduronidase Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 68. APAC Alpha L-Iduronidase Sales Forecast by Region (2025-2030) & (K Units)

    Table 69. APAC Alpha L-Iduronidase Revenue Forecast by Region (2025-2030) & ($ millions)

    Table 70. Europe Alpha L-Iduronidase Sales Forecast by Country (2025-2030) & (K Units)

    Table 71. Europe Alpha L-Iduronidase Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 72. Middle East & Africa Alpha L-Iduronidase Sales Forecast by Country (2025-2030) & (K Units)

    Table 73. Middle East & Africa Alpha L-Iduronidase Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 74. Global Alpha L-Iduronidase Sales Forecast by Type (2025-2030) & (K Units)

    Table 75. Global Alpha L-Iduronidase Revenue Forecast by Type (2025-2030) & ($ Millions)

    Table 76. Global Alpha L-Iduronidase Sales Forecast by Application (2025-2030) & (K Units)

    Table 77. Global Alpha L-Iduronidase Revenue Forecast by Application (2025-2030) & ($ Millions)

    Table 78. ArmaGen Inc Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

    Table 79. ArmaGen Inc Alpha L-Iduronidase Product Portfolios and Specifications

    Table 80. ArmaGen Inc Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 81. ArmaGen Inc Main Business

    Table 82. ArmaGen Inc Latest Developments

    Table 83. BioStrategies LC Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

    Table 84. BioStrategies LC Alpha L-Iduronidase Product Portfolios and Specifications

    Table 85. BioStrategies LC Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 86. BioStrategies LC Main Business

    Table 87. BioStrategies LC Latest Developments

    Table 88. Denali Therapeutics Inc Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

    Table 89. Denali Therapeutics Inc Alpha L-Iduronidase Product Portfolios and Specifications

    Table 90. Denali Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 91. Denali Therapeutics Inc Main Business

    Table 92. Denali Therapeutics Inc Latest Developments

    Table 93. EdiGene Inc Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

    Table 94. EdiGene Inc Alpha L-Iduronidase Product Portfolios and Specifications

    Table 95. EdiGene Inc Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 96. EdiGene Inc Main Business

    Table 97. EdiGene Inc Latest Developments

    Table 98. Gain Therapeutics Inc Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

    Table 99. Gain Therapeutics Inc Alpha L-Iduronidase Product Portfolios and Specifications

    Table 100. Gain Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 101. Gain Therapeutics Inc Main Business

    Table 102. Gain Therapeutics Inc Latest Developments

    Table 103. Immusoft Corp Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

    Table 104. Immusoft Corp Alpha L-Iduronidase Product Portfolios and Specifications

    Table 105. Immusoft Corp Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 106. Immusoft Corp Main Business

    Table 107. Immusoft Corp Latest Developments

    Table 108. JCR Pharmaceuticals Co Ltd Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

    Table 109. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product Portfolios and Specifications

    Table 110. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 111. JCR Pharmaceuticals Co Ltd Main Business

    Table 112. JCR Pharmaceuticals Co Ltd Latest Developments

    Table 113. Orchard Therapeutics Plc Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

    Table 114. Orchard Therapeutics Plc Alpha L-Iduronidase Product Portfolios and Specifications

    Table 115. Orchard Therapeutics Plc Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 116. Orchard Therapeutics Plc Main Business

    Table 117. Orchard Therapeutics Plc Latest Developments

    Table 118. Ossianix Inc Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

    Table 119. Ossianix Inc Alpha L-Iduronidase Product Portfolios and Specifications

    Table 120. Ossianix Inc Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 121. Ossianix Inc Main Business

    Table 122. Ossianix Inc Latest Developments

    Table 123. Rain Bio Inc Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

    Table 124. Rain Bio Inc Alpha L-Iduronidase Product Portfolios and Specifications

    Table 125. Rain Bio Inc Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 126. Rain Bio Inc Main Business

    Table 127. Rain Bio Inc Latest Developments

    Table 128. RegenxBio Inc Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

    Table 129. RegenxBio Inc Alpha L-Iduronidase Product Portfolios and Specifications

    Table 130. RegenxBio Inc Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 131. RegenxBio Inc Main Business

    Table 132. RegenxBio Inc Latest Developments

    Table 133. Tega Therapeutics Inc Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

    Table 134. Tega Therapeutics Inc Alpha L-Iduronidase Product Portfolios and Specifications

    Table 135. Tega Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 136. Tega Therapeutics Inc Main Business

    Table 137. Tega Therapeutics Inc Latest Developments

List of Figures

    Figure 1. Picture of Alpha L-Iduronidase

    Figure 2. Alpha L-Iduronidase Report Years Considered

    Figure 3. Research Objectives

    Figure 4. Research Methodology

    Figure 5. Research Process and Data Source

    Figure 6. Global Alpha L-Iduronidase Sales Growth Rate 2019-2030 (K Units)

    Figure 7. Global Alpha L-Iduronidase Revenue Growth Rate 2019-2030 ($ Millions)

    Figure 8. Alpha L-Iduronidase Sales by Region (2019, 2023 & 2030) & ($ Millions)

    Figure 9. Product Picture of IDUA

    Figure 10. Product Picture of EC 3.2.1.76

    Figure 11. Global Alpha L-Iduronidase Sales Market Share by Type in 2023

    Figure 12. Global Alpha L-Iduronidase Revenue Market Share by Type (2019-2024)

    Figure 13. Alpha L-Iduronidase Consumed in Oncology

    Figure 14. Global Alpha L-Iduronidase Market: Oncology (2019-2024) & (K Units)

    Figure 15. Alpha L-Iduronidase Consumed in Dermatology

    Figure 16. Global Alpha L-Iduronidase Market: Dermatology (2019-2024) & (K Units)

    Figure 17. Alpha L-Iduronidase Consumed in Immunology

    Figure 18. Global Alpha L-Iduronidase Market: Immunology (2019-2024) & (K Units)

    Figure 19. Alpha L-Iduronidase Consumed in Musculoskeletal Disorders

    Figure 20. Global Alpha L-Iduronidase Market: Musculoskeletal Disorders (2019-2024) & (K Units)

    Figure 21. Global Alpha L-Iduronidase Sales Market Share by Application (2023)

    Figure 22. Global Alpha L-Iduronidase Revenue Market Share by Application in 2023

    Figure 23. Alpha L-Iduronidase Sales Market by Company in 2023 (K Units)

    Figure 24. Global Alpha L-Iduronidase Sales Market Share by Company in 2023

    Figure 25. Alpha L-Iduronidase Revenue Market by Company in 2023 ($ Million)

    Figure 26. Global Alpha L-Iduronidase Revenue Market Share by Company in 2023

    Figure 27. Global Alpha L-Iduronidase Sales Market Share by Geographic Region (2019-2024)

    Figure 28. Global Alpha L-Iduronidase Revenue Market Share by Geographic Region in 2023

    Figure 29. Americas Alpha L-Iduronidase Sales 2019-2024 (K Units)

    Figure 30. Americas Alpha L-Iduronidase Revenue 2019-2024 ($ Millions)

    Figure 31. APAC Alpha L-Iduronidase Sales 2019-2024 (K Units)

    Figure 32. APAC Alpha L-Iduronidase Revenue 2019-2024 ($ Millions)

    Figure 33. Europe Alpha L-Iduronidase Sales 2019-2024 (K Units)

    Figure 34. Europe Alpha L-Iduronidase Revenue 2019-2024 ($ Millions)

    Figure 35. Middle East & Africa Alpha L-Iduronidase Sales 2019-2024 (K Units)

    Figure 36. Middle East & Africa Alpha L-Iduronidase Revenue 2019-2024 ($ Millions)

    Figure 37. Americas Alpha L-Iduronidase Sales Market Share by Country in 2023

    Figure 38. Americas Alpha L-Iduronidase Revenue Market Share by Country in 2023

    Figure 39. Americas Alpha L-Iduronidase Sales Market Share by Type (2019-2024)

    Figure 40. Americas Alpha L-Iduronidase Sales Market Share by Application (2019-2024)

    Figure 41. United States Alpha L-Iduronidase Revenue Growth 2019-2024 ($ Millions)

    Figure 42. Canada Alpha L-Iduronidase Revenue Growth 2019-2024 ($ Millions)

    Figure 43. Mexico Alpha L-Iduronidase Revenue Growth 2019-2024 ($ Millions)

    Figure 44. Brazil Alpha L-Iduronidase Revenue Growth 2019-2024 ($ Millions)

    Figure 45. APAC Alpha L-Iduronidase Sales Market Share by Region in 2023

    Figure 46. APAC Alpha L-Iduronidase Revenue Market Share by Regions in 2023

    Figure 47. APAC Alpha L-Iduronidase Sales Market Share by Type (2019-2024)

    Figure 48. APAC Alpha L-Iduronidase Sales Market Share by Application (2019-2024)

    Figure 49. China Alpha L-Iduronidase Revenue Growth 2019-2024 ($ Millions)

    Figure 50. Japan Alpha L-Iduronidase Revenue Growth 2019-2024 ($ Millions)

    Figure 51. South Korea Alpha L-Iduronidase Revenue Growth 2019-2024 ($ Millions)

    Figure 52. Southeast Asia Alpha L-Iduronidase Revenue Growth 2019-2024 ($ Millions)

    Figure 53. India Alpha L-Iduronidase Revenue Growth 2019-2024 ($ Millions)

    Figure 54. Australia Alpha L-Iduronidase Revenue Growth 2019-2024 ($ Millions)

    Figure 55. China Taiwan Alpha L-Iduronidase Revenue Growth 2019-2024 ($ Millions)

    Figure 56. Europe Alpha L-Iduronidase Sales Market Share by Country in 2023

    Figure 57. Europe Alpha L-Iduronidase Revenue Market Share by Country in 2023

    Figure 58. Europe Alpha L-Iduronidase Sales Market Share by Type (2019-2024)

    Figure 59. Europe Alpha L-Iduronidase Sales Market Share by Application (2019-2024)

    Figure 60. Germany Alpha L-Iduronidase Revenue Growth 2019-2024 ($ Millions)

    Figure 61. France Alpha L-Iduronidase Revenue Growth 2019-2024 ($ Millions)

    Figure 62. UK Alpha L-Iduronidase Revenue Growth 2019-2024 ($ Millions)

    Figure 63. Italy Alpha L-Iduronidase Revenue Growth 2019-2024 ($ Millions)

    Figure 64. Russia Alpha L-Iduronidase Revenue Growth 2019-2024 ($ Millions)

    Figure 65. Middle East & Africa Alpha L-Iduronidase Sales Market Share by Country in 2023

    Figure 66. Middle East & Africa Alpha L-Iduronidase Revenue Market Share by Country in 2023

    Figure 67. Middle East & Africa Alpha L-Iduronidase Sales Market Share by Type (2019-2024)

    Figure 68. Middle East & Africa Alpha L-Iduronidase Sales Market Share by Application (2019-2024)

    Figure 69. Egypt Alpha L-Iduronidase Revenue Growth 2019-2024 ($ Millions)

    Figure 70. South Africa Alpha L-Iduronidase Revenue Growth 2019-2024 ($ Millions)

    Figure 71. Israel Alpha L-Iduronidase Revenue Growth 2019-2024 ($ Millions)

    Figure 72. Turkey Alpha L-Iduronidase Revenue Growth 2019-2024 ($ Millions)

    Figure 73. GCC Country Alpha L-Iduronidase Revenue Growth 2019-2024 ($ Millions)

    Figure 74. Manufacturing Cost Structure Analysis of Alpha L-Iduronidase in 2023

    Figure 75. Manufacturing Process Analysis of Alpha L-Iduronidase

    Figure 76. Industry Chain Structure of Alpha L-Iduronidase

    Figure 77. Channels of Distribution

    Figure 78. Global Alpha L-Iduronidase Sales Market Forecast by Region (2025-2030)

    Figure 79. Global Alpha L-Iduronidase Revenue Market Share Forecast by Region (2025-2030)

    Figure 80. Global Alpha L-Iduronidase Sales Market Share Forecast by Type (2025-2030)

    Figure 81. Global Alpha L-Iduronidase Revenue Market Share Forecast by Type (2025-2030)

    Figure 82. Global Alpha L-Iduronidase Sales Market Share Forecast by Application (2025-2030)

    Figure 83. Global Alpha L-Iduronidase Revenue Market Share Forecast by Application (2025-2030)

Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
"ArmaGen Inc"|||"BioStrategies LC"|||"Denali Therapeutics Inc"|||"EdiGene Inc"|||"Gain Therapeutics Inc"|||"Immusoft Corp"|||"JCR Pharmaceuticals Co Ltd"|||"Orchard Therapeutics Plc"|||"Ossianix Inc"|||"Rain Bio Inc"|||"RegenxBio Inc"|||"Tega Therapeutics Inc"
Frequently Asked Questions
Alpha L-Iduronidase report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Alpha L-Iduronidase report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Alpha L-Iduronidase report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports